The prognostic landscape of genes and infiltrating immune cells in cytokine induced killer cell treated-lung squamous cell carcinoma and adenocarcinoma

OBJECTIVE: Patients with non–small cell lung cancer (NSCLC) respond differently to cytokine-induced killer cell (CIK) treatment. Therefore, potential prognostic markers to identify patients who would benefit from CIK treatment must be elucidated. The current research aimed at identifying predictive...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jian, Yang, Fan, Sun, Qian, Zeng, Ziqing, Liu, Min, Yu, Wenwen, Zhang, Peng, Yu, Jinpu, Yang, Lili, Zhang, Xinwei, Ren, Xiubao, Wei, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Compuscript 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610154/
https://www.ncbi.nlm.nih.gov/pubmed/34459571
http://dx.doi.org/10.20892/j.issn.2095-3941.2021.0023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610154/
https://www.ncbi.nlm.nih.gov/pubmed/34459571
http://dx.doi.org/10.20892/j.issn.2095-3941.2021.0023

Ejemplares similares